Patent opinions from the Eastern District of Texas and the U.S. Court of Appeals for the Federal Circuit

Weekly Digest
Fed. Cir.

In re Akerman, No. 25-107 (Fed. Cir. Feb. 4, 2025)

Denied
Court
U.S. Court of Appeals for the Federal Circuit
Case No.
No. 25-107
Decided
February 4, 2025
Judge
Per curiam
Document
Order on Motion
Length
2 pages

NOTE: This order is nonprecedential. United States Court of Appeals

for the Federal Circuit

In Re MARTIN AKERMAN, I,

Petitioner

2025-107

On Petition for Writ of Mandamus to the Merit Systems Protection Board in Nos. DC-1221-22-0257-W-2 and DC-1221-22-0445-W-2.

ON MOTION AND PETITION

Before LOURIE, MAYER, and HUGHES, Circuit Judges.

O R D E R

Martin Akerman, I, petitions this court for a writ of mandamus to compel the Merit Systems Protection Board to take certain action in his Board appeals, Nos. DC-1221-22-0257-W-2 and DC-1221-22-0445-W-2. Mr. Akerman also moves for various relief, including to hold this matter “in abeyance for 180 days” so that other of his cases may “proceed to resolution.” ECF No. 15 at 4.

Mr. Akerman’s petition seeks to compel the Board to rule on his stay requests and to document a status conference held with the administrative judge. The All Writs Act

22 IN RE AKERMAN

provides that federal courts “may issue all writs necessary or appropriate in aid of their respective jurisdictions and agreeable to the usages and principles of law.” 28 U.S.C. § 1651(a). Mandamus is an extraordinary remedy available only where the petitioner shows: (1) a clear and indisputable right to relief; (2) no adequate alternative avenue for relief; and (3) that mandamus is appropriate under the circumstances. Cheney v. U.S. Dist. Ct. for D.C., 542 U.S. 367, 380–81 (2004). At a minimum, Mr. Akerman has not shown a clear and indisputable right to the relief requested. We thus deny mandamus relief. Accordingly,

IT IS ORDERED THAT:

The petition and all pending motions are denied.

FOR THE COURT

Figure on page 2 of the opinion

February 4, 2025 Date

Text extracted from the official PDF and reflowed for reading. It is not a certified transcript — the PDF linked above is the authoritative document.

Analysis is coming soon.

A plain-English account of the issues, facts and holding, written by Patent Case Watch. The opinion itself — its full text, its PDF and everything else on this page — stays free to read for everyone, always.

Cite this opinion

In re Akerman, No. 25-107 (Fed. Cir. Feb. 4, 2025).

Record ID
CAFC-25-107-20250204
Permalink
https://patentcasewatch.com/opinions/CAFC-25-107-20250204

No reporter citation is shown because the official source does not supply one; none is inferred here. Check the opinion and a citator before relying on this form.